Health
China Zhifei’s COVID vaccine largely works on delta variant: study – Nikkei Asia
Efficacy results from Phase 3 clinical trial yet to be published
BEIJING (Reuters) — A COVID-19 vaccine developed by a unit of China’s Chongqing Zhifei Biological Products largely retained its neutralising effect against the Delta variant but there was a slight reduction, Chinese researchers found in a laboratory study.
…
Continue Reading
-
General15 hours agoChina and Philippines trade blame over latest South China Sea clash
-
Noosa News24 hours agoConfusion over licensing and access to hunting grounds under WA’s strict gun laws
-
General15 hours agoOf saints and sinners | The Spectator Australia
-
Noosa News19 hours agoBrisbane rising on global rankings, but still behind southern capitals